Loblaw said a boycott of its stores during its latest quarter had a minimal impact, as the company attributed lower profits to a settlement over an alleged bread price-fixing scheme.
Loblaw attributed that in part to the company's strong performance a year earlier, making it a tough comparison. Regarding the boycott, “we did notice a bit of an impact in certain stores in specific markets, but that said, at the end of the quarter, things have returned to normal,” said Dufresne. Drug retail same-store sales increased 1.5 per cent, with front store same-store sales down 2.4 per cent and pharmacy and health-care services same-store sales up 5.4 per cent.